Interventional Cardiology and Angiology




Prevention of Restenosis - Molecular basics

  • The pathogenesis of the human restenotic lesions after angioplasty is not well defined, but there is a consensus that restenosis involves the interaction of cytokines, growth factors, vascular and blood cellular elements, and the extent of injury.
  • The restenosis process can be divided into 3 or 4 phases:
    • Thrombus formation, local inflammation, proliferation and matrix formation.
  • So far, the most pharmacological and interventional attempts to reduce restenosis were focused on the reduction of thrombus formation.
  • Phase 3 proliferation:
    • Local stimulation of cell proliferation: FGF, PDGF, Thrombin, TGF-beta
  • Phase 3 migration:
    • PDGF-BB, TGF-beta
  • Angiotensin II:
    • AngII binds to G-protein-coupled AT1 receptor:
    • Activation of phospholipase C and release of calcium, stimulation of protein kinase C. Ang II stimulates also the activity of phospholipase D.
    • Activation of mitogen-activated protein kinase
    • Regulation of c-fos expression


Universitätsklinikum Charité - Medizinische Fakultät der Humboldt-Universität zu Berlin, Campus Berlin-Buch

Franz-Volhard-Klinik
Wiltbergstraße 50, D - 13125 Berlin
Tel.: +49 30 9417 2996 - Fax: +49 30 9497 074

Letzte Änderung: 17.11.98 - © 1998 - webmaster